Secondary Navigation Menu

Audience Switcher Modal

Country and Audience Choose Modal

Some of the compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities.

Scientific Congress Publications

Supported by Bayer Pharmaceuticals

AAN 2026

Factor XIa Inhibition with Asundexian in Acute Non-cardioembolic Stroke or High-risk Transient Ischemic Attack: Primary Results of the OCEANIC-STROKE Trial
Date/Time:
Tuesday, April 21, 2026 | 9:15 AM – 11:30 AM, CT
Presenting Author:
Mukul Sharma
Session Type:
Clinical Trials Plenary Session – PL5
Download the presentation
Incidence and Recurrence of Ischemic Stroke in a Large Midwestern Healthcare System
Date/Time:
Tuesday, April 21, 2026 / 11:45 AM – 12:45 PM, CT
Presenting Author:
Emily Durden
Poster Session:
Poster Abstract Session 08
Download the poster
Back to Stroke Prevention

© 2026 Bayer. All rights reserved.
Bayer and the Bayer Cross are registered trademarks of Bayer.

Copies of the Bayer Pharmaceuticals supported presentations obtained from this platform are for personal use only and may not be reproduced or distributed without permission from the authors.

Some of the compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities, and the presentations are shared in the interest of scientific exchange.

For any questions, please contact Medical Information at https://www.medicalinformation.bayer.com/

PP-GEN-ALL-0014-1